Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease

Luciana Rigoli, Placido Bramanti, Chiara Di Bella, Filippo De Luca

Research output: Contribution to journalReview article

Abstract

Wolfram syndrome 1 (WS1) is a rare autosomal recessive neurodegenerative disease characterized by diabetes insipidus, diabetes mellitus, optic atrophy, deafness, and other abnormalities. WS1 usually results in death before the age of 50 years. The pathogenesis of WS1 is ascribed to mutations of human WFS1 gene on chromosome 4p encoding a transmembrane protein called wolframin which has physiological functions in membrane trafficking, secretion, processing, and/or regulation of ER calcium homeostasis. Different types of WFS1 mutations have been identified, and some of these have been associated with a dominant, severe type of WS.

Original languageEnglish
Pages (from-to)921-929
Number of pages9
JournalPediatric Research
Volume83
Issue number5
DOIs
Publication statusPublished - May 2018

Fingerprint

Wolfram Syndrome
Neurodegenerative Diseases
Mutation
Homeostasis
Chromosomes
Calcium
Membranes
Genes

Cite this

Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease. / Rigoli, Luciana; Bramanti, Placido; Di Bella, Chiara; De Luca, Filippo.

In: Pediatric Research, Vol. 83, No. 5, 05.2018, p. 921-929.

Research output: Contribution to journalReview article

Rigoli, Luciana ; Bramanti, Placido ; Di Bella, Chiara ; De Luca, Filippo. / Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease. In: Pediatric Research. 2018 ; Vol. 83, No. 5. pp. 921-929.
@article{c5a9907e72c04da9a85e2be1676c8464,
title = "Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease",
abstract = "Wolfram syndrome 1 (WS1) is a rare autosomal recessive neurodegenerative disease characterized by diabetes insipidus, diabetes mellitus, optic atrophy, deafness, and other abnormalities. WS1 usually results in death before the age of 50 years. The pathogenesis of WS1 is ascribed to mutations of human WFS1 gene on chromosome 4p encoding a transmembrane protein called wolframin which has physiological functions in membrane trafficking, secretion, processing, and/or regulation of ER calcium homeostasis. Different types of WFS1 mutations have been identified, and some of these have been associated with a dominant, severe type of WS.",
author = "Luciana Rigoli and Placido Bramanti and {Di Bella}, Chiara and {De Luca}, Filippo",
year = "2018",
month = "5",
doi = "10.1038/pr.2018.17",
language = "English",
volume = "83",
pages = "921--929",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease

AU - Rigoli, Luciana

AU - Bramanti, Placido

AU - Di Bella, Chiara

AU - De Luca, Filippo

PY - 2018/5

Y1 - 2018/5

N2 - Wolfram syndrome 1 (WS1) is a rare autosomal recessive neurodegenerative disease characterized by diabetes insipidus, diabetes mellitus, optic atrophy, deafness, and other abnormalities. WS1 usually results in death before the age of 50 years. The pathogenesis of WS1 is ascribed to mutations of human WFS1 gene on chromosome 4p encoding a transmembrane protein called wolframin which has physiological functions in membrane trafficking, secretion, processing, and/or regulation of ER calcium homeostasis. Different types of WFS1 mutations have been identified, and some of these have been associated with a dominant, severe type of WS.

AB - Wolfram syndrome 1 (WS1) is a rare autosomal recessive neurodegenerative disease characterized by diabetes insipidus, diabetes mellitus, optic atrophy, deafness, and other abnormalities. WS1 usually results in death before the age of 50 years. The pathogenesis of WS1 is ascribed to mutations of human WFS1 gene on chromosome 4p encoding a transmembrane protein called wolframin which has physiological functions in membrane trafficking, secretion, processing, and/or regulation of ER calcium homeostasis. Different types of WFS1 mutations have been identified, and some of these have been associated with a dominant, severe type of WS.

U2 - 10.1038/pr.2018.17

DO - 10.1038/pr.2018.17

M3 - Review article

C2 - 29774890

VL - 83

SP - 921

EP - 929

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5

ER -